Purple Biotech (PPBT) Operating Leases (2018 - 2025)
Purple Biotech (PPBT) reported Operating Leases of $244000.0 for Q4 2025, up 33.33% year-over-year from $183000.0 in Q4 2024, and up 33.33% quarter-over-quarter from $183000.0 in Q4 2024.
Purple Biotech (PPBT) Operating Leases (2018 - 2025) Analysis & Trends
Purple Biotech (PPBT) has 8 years of Operating Leases data on file, last reported at $244000.0 in Q4 2025.
- Operating Leases for Q4 2025 came in at $244000.0, up 33.33% year-over-year; the trailing twelve-month figure through Dec 2025 was $244000.0 (up 33.33% YoY), and the FY2025 annual result was $244000.0, up 33.33% from the prior year.
- Operating Leases rose to $244000.0 in Q4 2025 per PPBT's latest filing, from $183000.0 in the prior quarter.
- Over five years, Operating Leases peaked at $622000.0 in Q1 2021 and troughed at $38000.0 in Q3 2024.
- A 5-year average of $320411.8 and a median of $278000.0 in 2023 frame the typical range for Operating Leases.
- The sharpest annual moves came in 2021 and 2024: Operating Leases jumped 7462.5% in 2021, then slumped 80.21% in 2024.
- A 5-year view of Operating Leases shows it stood at $550000.0 in 2021, then sank by 41.64% to $321000.0 in 2022, then plunged by 49.22% to $163000.0 in 2023, then gained by 12.27% to $183000.0 in 2024, then soared by 33.33% to $244000.0 in 2025.
- Business Quant data shows PPBT's Operating Leases at $244000.0 in Q4 2025, $183000.0 in Q4 2024, and $38000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Purple Biotech | 261.30 Mn | 254.88 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 244,000.00 |
| Dec 31, 2024 | 183,000.00 |
| Sep 30, 2024 | 38,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 121,000.00 |
| Dec 31, 2023 | 163,000.00 |
| Sep 30, 2023 | 192,000.00 |
| Jun 30, 2023 | 237,000.00 |
| Mar 31, 2023 | 278,000.00 |
| Dec 31, 2022 | 321,000.00 |
| Sep 30, 2022 | 357,000.00 |
| Jun 30, 2022 | 399,000.00 |
| Mar 31, 2022 | 495,000.00 |
| Dec 31, 2021 | 550,000.00 |
| Sep 30, 2021 | 563,000.00 |
| Jun 30, 2021 | 605,000.00 |
| Mar 31, 2021 | 622,000.00 |
| Dec 31, 2020 | 1.05 Mn |
| Jun 30, 2020 | 8,000.00 |
| Dec 31, 2019 | 28,000.00 |